U.S. Capital Markets Stock News

NYSE:RACE
NYSE:RACEAuto

Ferrari (RACE) Could Be 6% Undervalued Following Its Recent Share Price Run

Ferrari (NYSE:RACE) is back in focus after its recent share price move, with the stock closing at $414.85 on 13 August 2026. Investors are reassessing the company’s valuation and recent performance metrics. See our latest analysis for Ferrari. For context, Ferrari’s recent 1 month share price return of 10.41% and 3 month share price return of 29.16% point to building momentum, even though the 1 year total shareholder return declined 8.88% and the 5 year total shareholder return sits at...
NYSE:HWM
NYSE:HWMAerospace & Defense

Howmet (HWM) Stock Could Look Overvalued As Raised Guidance Lands

Howmet Aerospace stock has delivered very strong multi year returns, yet at around US$289 per share the Discounted Cash Flow (DCF) intrinsic value estimate and the market based valuation checks both point to a premium price rather than a clear bargain. Howmet Aerospace has returned about 8x over the past 5 years, which puts extra focus on whether the current price already embeds optimistic expectations. Recent earnings growth and higher expectations for aerospace demand can support a...
NYSE:UAMY
NYSE:UAMYMetals and Mining

United States Antimony (UAMY) Is Down 19.6% After Swinging To First-Half 2026 Net Loss - What's Changed

United States Antimony Corporation has now reported its past second-quarter 2026 results, with sales of US$7.93 million and net income of US$110,290, down from sales of US$10.53 million and net income of US$181,555 a year earlier. For the first half of 2026, sales fell to US$14.71 million while the company swung from net income of US$728,079 to a net loss of US$11.18 million, highlighting a sharp deterioration in profitability despite earlier growth expectations. We’ll now examine how this...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Analog Devices (ADI) Sees Growth Projections Climb, Is The Valuation Too Pricey?

Recent projections around Analog Devices (ADI) have put the stock in focus, as analysts expect sharp year over year increases in quarterly earnings and revenue tied to industrial and data center demand. See our latest analysis for Analog Devices. At a share price of US$389.39, Analog Devices has seen strong positive momentum this year, with a 42.25% year to date share price return and a 70.37% total shareholder return over the past 12 months. This suggests investors are reassessing both...
NasdaqGS:BANR
NasdaqGS:BANRBanks

Banner (BANR) Stock Looks Cheap On Fair Value Yet Full On Earnings

Banner stock has delivered a strong 85.0% return over the past three years, and the current Excess Returns intrinsic value estimate still points to the shares trading at a sizeable discount to that assessment. At the same time, traditional market multiples suggest the pricing is about right, which puts extra focus on how investors read the recent move and the new buyback plan. Over the last three years, Banner has returned 85.0%. This places more weight on whether the current price already...
NYSE:LVS
NYSE:LVSHospitality

How Investors Are Reacting To Las Vegas Sands (LVS) Earnings Miss And Bearish Analyst Revisions

In 2026, Las Vegas Sands reported quarterly results that missed analyst expectations, with earnings per share falling well short and revenue also coming in below consensus, alongside a year-over-year earnings decline. Analyst sentiment has weakened as earnings forecasts were revised downward and the stock received a bearish ranking, highlighting growing concern about the company’s near-term profit trajectory. Next, we’ll explore how these weaker-than-expected earnings and negative revisions...
NYSE:CVS
NYSE:CVSHealthcare

How Investors May Respond To CVS (CVS) Earnings Upgrade And Expanded GLP-1 Weight Loss Platform

In early August 2026, CVS Health reported second-quarter sales of US$35,117 million and net income of US$2,979 million, while raising full-year GAAP diluted EPS guidance to US$6.84–US$7.04 and projecting at least US$414.00 billion in revenue and up to US$9.07 billion in net income attributable to CVS Health. At the same time, CVS Health overhauled its weight management offering around GLP-1 therapies, cutting MinuteClinic digital visit prices to US$29 and partnering with Eli Lilly to...
NYSE:MAN
NYSE:MANProfessional Services

Could ManpowerGroup’s (MAN) New Board Pick Subtly Reframe Its HR Tech and Platform Ambitions?

Earlier this week, ManpowerGroup announced that Paychex President and CEO John B. Gibson, Jr. will join its Board of Directors effective September 1, 2026, bringing decades of experience in human capital management, technology, and global HR services. Gibson’s background in scaling digital HR platforms and executing large acquisitions, such as Paychex’s purchase of Paycor, could inform how ManpowerGroup advances its own technology and service offering mix. We’ll now explore how adding...
NYSEAM:FJET
NYSEAM:FJETAerospace & Defense

Does Starfighters Space’s (FJET) 10-Q Delay Complicate Its Financial Transparency Narrative?

On 14 August 2026, Starfighters Space, Inc. reported it would miss the SEC deadline for filing its next Form 10-Q, signaling a delay in its quarterly financial disclosure. This filing delay can draw attention because it often points to underlying financial reporting or operational complexities that investors will watch closely. Next, we examine how Starfighters Space’s delayed 10-Q filing could shape its investment narrative and influence perceptions of financial transparency. AI is about...
NYSE:AON
NYSE:AONInsurance

Aon (AON) Taps Darren Van’t Hof To Deepen Its Renewable Tax Credit Push

Aon (NYSE:AON) appointed Darren Van’t Hof as Head of Tax Credit Financing, Transaction Solutions, to lead its tax credit insurance efforts in renewable energy. Van’t Hof is a nationally recognized renewable energy finance and policy leader, with prior roles including interim President and CEO of the Solar Energy Industries Association. He previously led U.S. Bancorp's Impact Finance business, which adds experience in sustainable finance and energy transition to Aon's advisory...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Workday (WDAY) As Silver Lake Talks Recast The Narrative Around Valuation

Workday (WDAY) has suddenly moved back into focus after reports that private equity firm Silver Lake is in talks to acquire the cloud software company, with the news sending the stock sharply higher. See our latest analysis for Workday. Beyond the Silver Lake headlines, Workday's share price has swung sharply, with a 40.09% 30 day share price return and 58.93% 90 day share price return. However, a 12.12% decline in 1 year total shareholder return shows longer term holders are still under...
NasdaqGS:URBN
NasdaqGS:URBNSpecialty Retail

Urban Outfitters (URBN) Could Be 10% Undervalued Following Recent Operating Gains

Recent operating gains put Urban Outfitters stock in focus Urban Outfitters (URBN) has drawn fresh investor attention after reporting 4.8% same-store sales growth alongside a 4.6% annual rise in store count over the past two years, highlighting recent operational momentum. See our latest analysis for Urban Outfitters. At a share price of US$77.81, Urban Outfitters has seen a 12.85% 90 day share price return, while its 3 year total shareholder return of 117.71% shows how strongly longer term...
NasdaqGS:LIN
NasdaqGS:LINChemicals

How Europe’s Liquid Hydrogen Build-Out And Market Share Gains At Linde (LIN) Has Changed Its Investment Story

Recently, Europe’s liquid hydrogen market was reported as expanding from about US$7.20 billion in 2026 to a projected US$13.10 billion by 2035, supported by stricter decarbonization mandates and rising infrastructure investment, with Linde holding an estimated share above 22% and enlarging its distribution footprint. This growth trajectory underlines how Linde’s established position in hydrogen and its role in hard-to-abate sectors could enhance its exposure to Europe’s deep decarbonization...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

Does Adding Jim Yong Kim to Leadership Shift ImmunityBio’s Global Strategy Narrative (IBRX)?

Earlier this month, ImmunityBio, Inc. appointed former World Bank president Dr. Jim Yong Kim as Vice Chairman, creating an Office of the Executive Chairman to concentrate on global strategy, partnerships, and international access to the company’s immunotherapy platform and approved therapies outside the United States. By adding a leader with deep experience in global health and multilateral institutions, ImmunityBio is signaling an intent to deepen its engagement with governments and public...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Is Gen Digital (GEN) Still A Bargain After Raised Guidance?

Gen Digital stock has delivered a 47.6% gain over the past three years, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both still point to the shares trading at a discount to what the underlying cash flows suggest. Over the past three years, Gen Digital has returned 47.6%, which indicates that long term holders have already seen a solid payoff from staying invested. Growing demand for the company’s cybersecurity offerings can...
NYSE:VLTO
NYSE:VLTOCommercial Services

Why Veralto (VLTO) Is Back In The Spotlight

Veralto (VLTO) is back in focus after investors responded to improving earnings estimates, a supportive outlook tied to U.S. infrastructure and semiconductor demand, and the recent acquisition of In-Situ Inc. in environmental water monitoring. See our latest analysis for Veralto. Over the past quarter, Veralto’s share price return of 15.15% and 1 month share price return of 7.34% suggest momentum has been building, although the 1 year total shareholder return is still down 8.45% from earlier...
NasdaqGS:KTOS
NasdaqGS:KTOSAerospace & Defense

Kratos Defense & Security Solutions (KTOS) Stock In Focus As US Tariffs Hit Imported Drones

Kratos Defense & Security Solutions (NasdaqGS:KTOS) is in focus after the US government announced new tariffs on imported drones and key components. The measures aim to shift demand toward domestically produced systems and reduce US reliance on foreign drone suppliers. As a US based drone and defense technology provider, Kratos is positioned within the group of manufacturers that could experience changing competitive conditions as a result of the policy shift. Consider broadening your...
NYSE:DHI
NYSE:DHIConsumer Durables

D.R. Horton (DHI) Pulls Back As Undervaluation Comes Into Focus, Is The Stock Still Cheap?

D.R. Horton (DHI) has drawn investor attention after recent share price moves, with the stock down 1.8% over the past month but up about 9.9% in the past 3 months. See our latest analysis for D.R. Horton. At a share price of $148.81, D.R. Horton has seen share price momentum cool over the past month, even though the 3 year total shareholder return of 30.88% and 5 year total shareholder return of 65.18% still point to a stronger longer term outcome. If recent moves in D.R. Horton have you...
NasdaqGS:GTM
NasdaqGS:GTMInteractive Media and Services

ZoomInfo Technologies (GTM) Raises Guidance, Is The Stock Still Cheap?

ZoomInfo Technologies (GTM) has drawn fresh attention after its second quarter results, where management highlighted 20% growth in the operations business, secured the largest contract in company history, and raised full-year revenue and adjusted EPS guidance. See our latest analysis for ZoomInfo Technologies. Despite the raised guidance and new AI-related partnerships, ZoomInfo Technologies' share price return tells a mixed story, with a strong 31.5% gain over the past month but a much...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines (ONC) Secures Rights To Four RAS(ON) Inhibitors In Asia

BeOne Medicines (NasdaqGS: ONC) announces a multi-part collaboration with Revolution Medicines focused on oncology RAS(ON) inhibitors. The agreement gives BeOne access to four advanced-stage RAS(ON) inhibitors and includes joint clinical studies for combination cancer therapies. BeOne secures exclusive development and commercialization rights for these RAS(ON) assets in select Asian markets. This type of oncology partnership highlights how drug developers and healthcare technology companies...
NYSE:XYZ
NYSE:XYZDiversified Financial

Block (XYZ) Opens Bitcoin Payments To Merchants With No Fees Until 2027

Block (NYSE:XYZ) enabled Bitcoin payments on its Square point-of-sale terminals for merchants, with no processing fees until 2027. The move is framed by investor Tim Draper as a step toward broader Bitcoin use in everyday commerce. Merchants using Square can now accept Bitcoin alongside traditional payment methods at checkout. Block is far from the only company tied to the growth of crypto payments and wider blockchain adoption. It can be useful to compare this news with a broader group of...
NYSE:KNX
NYSE:KNXTransportation

What Knight-Swift Transportation Holdings (KNX)'s Dividend And Safety Edge Reveal About Its Competitive Position

Knight-Swift Transportation Holdings Inc. previously declared a quarterly cash dividend of US$0.20 per share, payable on September 21, 2026, to stockholders of record as of September 4, 2026, under its board-approved dividend policy and subject to ongoing quarterly review. At the same time, improving freight conditions and tighter safety scrutiny on smaller carriers have drawn attention to how Knight-Swift’s scale and compliance capabilities may shape its competitive position. We’ll now...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

CSX (CSX) On Infrastructure Upgrades And Solid Results Looks Near Fair Value

CSX stock’s recent run and what it might mean for you CSX (CSX) has drawn attention after its shares outpaced the S&P 500 by 9.7% over the past six months, supported by quarterly results that were described as solid while occurring alongside weaker sales volumes and a softer free cash flow margin. See our latest analysis for CSX. Over the past year, CSX has combined steady short term momentum with meaningful long term wealth creation, with a 38.3% year to date share price return and a 5 year...
NasdaqGS:ECHO
NasdaqGS:ECHOMedia

EchoStar (ECHO) Could Be 109% Overvalued On Its Earnings Turnaround

EchoStar (ECHO) has drawn fresh attention after second quarter results showed revenue of US$3.58b compared with US$3.72b a year earlier, alongside a shift from a net loss to net income of US$8.46b. See our latest analysis for EchoStar. EchoStar's latest earnings swing to net income and the update on its completed share repurchase programme have come alongside a 1-year total shareholder return of 229.83%, even as the 90-day share price return declined 33.04%. This suggests recent momentum has...